Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Serious Treatment for Serious Acne: Unleashing the Power of Isotretinoin

Christopher Byrne, RPA-C with Advanced Dermatology PC, Offers Tips on How Isotretinoin Can Clear Stubborn Acne.


News provided by

Advanced Dermatology P.C.

Mar 08, 2021, 10:15 ET

Share this article

Share toX

Share this article

Share toX

Chris Byrne, RPA-C
Chris Byrne, RPA-C

FRANKLIN SQUARE, N.Y., March 8, 2021 /PRNewswire-PRWeb/ -- "Yes, acne is commonplace," notes Christopher Byrne, a certified registered physician's assistant specializing in dermatology with Advanced Dermatology PC. "But for some people, it's a serious skin problem, carrying an immense psychological burden and, if left untreated, causing permanent scarring. Fortunately, we have an effective means of treating serious acne: the powerful oral retinoid isotretinoin."

Approved by the FDA in 1982 under the brand name Accutane, isotretinoin was a game changer for treating severe nodular acne. "It kicks in on all cylinders in terms of addressing the root causes," explains Byrne, "including the overproduction of the skin oil sebum, inflammation, and proliferation of the namesake skin bacteria p. acnes."

Fortunately, we have an effective means of treating serious acne: the powerful oral retinoid isotretinoin.

Post this

A convergence of factors, including hormones, genetics, and stress, can trigger the country's most common skin condition: As many as 50 million struggle with acne, the American Academy of Dermatology (AAD) reports.

"If our skin's natural regeneration gets disrupted," says Byrne, "pimples result: Sebum skin oil clogs the pores, blocking dead skin cells from being expelled. This can lead to overgrowth of the bacteria p. acnes and escalating levels of inflammation. In serious cases, pimples can converge, and painful nodules can spread over larger sections of skin. Over-the-counter treatments, topical prescriptions, and other treatments may not be enough, and permanent scarring can result."

"Fortunately," continues Byrne, "when other treatments do not work, isotretinoin is an effective intervention against serious recalcitrant acne."

Today, isotretinoin is offered under the Accutane equivalents Amnesteen, Claravis, Myorisan, and Zenatane, as well as the distinct brand Absorica, which was formulated to increase absorption.

"Over the last several decades," notes Byrne, "isotretinoin has helps millions of people recover from serious acne. It is a powerful medication, however, so it's important that patients work with their dermatologist to understand possible side effects."

For patients considering isotretinoin, Byrne has the following suggestions:

5 Tips for Treating Acne with Isotretinoin:

1. Side effects need front-row awareness: "Isotretinoin can cause birth defects," emphasizes Byrne, "so both doctors and patients are required to participate in the FDA-mandated program iPledge, which calls for following strict rules regarding birth control and ongoing pregnancy tests. Doctors may also monitor patients' lipid and liver-enzyme levels, as these may be affected. Finally, there has been concern regarding a possible link between isotretinoin and depression, as well as with irritable bowel syndrome. Research has not shown links, and, due to severe acne's psychological toll, the ADD continues to endorse the benefit of treatment. That said, patients should stay aware and inform their doctor of any changes."

2. Moisturize, hydrate, and use sun protection: "Begin preventative maintenance immediately," advises Byrne. "Isotretinoin is drying, requiring gentle skin care and regular moisturizing after bathing or washing. Also, plenty of hydration: at least eight glasses of water daily. And it increases sun sensitivity, so, more than ever, protection is a must."

3. Consider graduated dosing: "We've seen that reaching a certain cumulative dose can help prevent relapse," says Byrne, "but, at first, isotretinoin can cause symptoms to flare. Patients may want to ask their doctors about starting with a lower dose that can be increased after the body adjusts."

4. Optimize absorption: "The Accutane-type brands," explains Byrne, "must be taken with a high-fat, high-calorie meal for the medicine to be fully absorbed. The Absorica formulation is designed to support absorption. Talk with your doctor about your prescription and how to optimize its effectiveness."

5. Finish the treatment course: "According to research," Byrne shares, "the total amount of isotretinoin taken can affect whether or not patients experience relapse, so patients should stick with the full course of treatment. Other factors can also play a role, including age. Fortunately, if necessary, retreatment is usually successful."

"For individuals contending with the serious problem of serious acne," concludes Byrne, "isotretinoin offers an effective solution."

Bio: Christopher Byrne RPA-C is a certified physician assistant with Advanced Dermatology PC.

Advanced Dermatology P.C. and the Center for Laser and Cosmetic Surgery (New York & New Jersey) is one of the leading dermatology centers in the nation, offering highly experienced physicians in the fields of cosmetic and laser dermatology as well as plastic surgery and state-of-the-art medical technologies. http://www.advanceddermatologypc.com

Media Contact

Melissa Chefec, MCPR, LLC, 2039686625, [email protected]

SOURCE Advanced Dermatology P.C.

Related Links

http://www.advanceddermatologypc.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.